20th Annual African Vaccinology Course (AAVC)

Day 3: Manufacturing & Delivering New and Underutilised Vaccines in Africa

Day 3 focuses on the critical challenges and opportunities in vaccine manufacturing and delivery across Africa. Sessions explore pandemic preparedness (The 100 Day Mission), advances in local manufacturing via the mRNA Hub, and the sustainable future of vaccine production. The agenda also covers key underutilised vaccines, including progress in TB, HIV, Malaria (RTS,S), and Meningococcal vaccines.

Key Learning Outcomes for the Day

  • Analyze Africa's pandemic preparedness in the context of the "100 Day Mission".
  • Describe recent advances in local vaccine manufacturing, including the mRNA Hub.
  • Review the current progress, promise, and pathways for TB, HIV, and Malaria vaccines in Africa.
  • Understand the intersection of clinical trials, regulation, and evidence-based practice in immunization policy.
  • Explore innovations and the path forward for Meningococcal vaccine programs in Africa.
Day 3 Detailed Program Schedule and Slide Downloads

Presentation Topic

Speaker (Name & Affiliation)

Slides (PDF)
The 100 Day Mission: Is Africa prepared for the next pandemic?Shingai Machingaidze, Coalition for Epidemic Preparedness Innovations, SADownlaod PDF 📄
Advances in local vaccine manufacturing capacity: Experiences from the mRNA Hub, AfrigenPia Steigler, Afrigen Biologics & Vaccines, SADownlaod PDF 📄
Vaccine production in Africa: Charting a sustainable way forwardMorena Makhoana, The Biovac Institute, SADownlaod PDF 📄
TB vaccines in Africa: Progress, promise, and pathways to significant public health impactThomas Scriba, South African TB Vaccine Innitiative, UCT, SADownlaod PDF 📄
HIV vaccines: 40 years on, where are we now? Strengthening efforts towards a breakthroughErica Andersen-Nissen, HIV Vaccine Trials Network, SADownlaod PDF 📄
Intersections between clinical trials, regulation and evidence-based practice in advancing immunization policiesCarine Dochez, Institute of Tropical Medicine, BelgiumDownlaod PDF 📄
Redefining the fight against malaria: Lessons from subnational introduction of the RTS,S/AS01 in Africa*Rose Jalang'o, National Vaccines and Immunization Programme, KenyaDownlaod PDF 📄
Meningococcal vaccines: Progress, innovation, and the path forward for AfricaLawrence Akunga, Sanofi, SADownlaod PDF 📄

Full Session Recording

Session Video (English)